Stratification of Intermediate-Risk Endometrial Cancer Patients Into Groups at High Risk or Low Risk for Recurrence Based on Tumor Gene Expression Profiles

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-1353
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Mismatch Repair Deficiency Identifies Patients With High-Intermediate-Risk (HIR) Endometrioid Endometrial Cancer at the Highest Risk of Recurrence: A Prognostic Biomarker

Cancer
Cancer ResearchOncology
2018English

Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- And High-Risk Patients

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

High Intermediate Risk Endometrial Cancer. What Is It?

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2019English

Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2015English

Metabolomic Analysis of Serum May Refine 21-Gene Expression Assay Risk Recurrence Stratification

npj Breast Cancer
OncologyRadiologyNuclear MedicinePharmacologyImaging
2019English

Low-Dose Rate Brachytherapy for Patients With Low- Or Intermediate-Risk Prostate Cancer: A Systematic Review

Canadian Urological Association Journal
Urology
2013English

A Computational Framework for Predicting Obesity Risk Based on Optimizing and Integrating Genetic Risk Score and Gene Expression Profiles

PLoS ONE
Multidisciplinary
2018English

On Risk Estimation Versus Risk Stratification in Early Prostate Cancer

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2016English

High-Grade Tumor Budding Stratifies Early-Stage Cervical Cancer With Recurrence Risk

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy